A Phase 1, Single-center, Randomized, 2-Way Cross-over, Open-label Study to Evaluate the Effect of Oral Repeated Doses of AZD1722 on the Pharmacokinetics of Oral Cefadroxil in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 22 Apr 2017
At a glance
- Drugs Tenapanor (Primary) ; Cefadroxil
- Indications Hyperphosphataemia; Irritable bowel syndrome; Kidney disorders
- Focus Pharmacokinetics
- Sponsors Ardelyx; AstraZeneca
- 22 Apr 2017 Results published in the British Journal of Clinical Pharmacology
- 14 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 01 Aug 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.